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Abstract 
Background: Patients with schizophrenia (SZP) have been reported to exhibit impairments in 
reward-based decision-making, but results are heterogeneous with multiple potential 
confounds such as age, intelligence level, clinical symptoms or medication, making it difficult 
to evaluate the robustness of these impairments.  
Methods: We conducted a meta-analysis of studies comparing the performance of SZP and 
healthy controls (HC) in the Iowa Gambling Task (IGT) as well as comprehensive analyses 
based on subject-level data (n = 303 SZP, n = 188 HC) to investigate reward-based decision-
making in SZP. To quantify differences in the influence of individual deck features (immediate 
gain, gain frequency, net loss) between SZP and HC, we additionally employed a least-squares 
model.  
Results: SZP showed statistically significant suboptimal decisions as indicated by 
disadvantageous deck choices (d from 0.51 to -0.62) and lower net scores (d from -0.35 to -
1.03) in a meta-analysis of k = 29 samples (n = 1127 SZP, n = 1149 HC) and these results were 
confirmed in a complementary subject-level analysis. Moreover, decision-making in SZP was 
characterized by a relative overweighting of immediate gain and net losses and an 
underweighting of gain frequency. Moderator analyses revealed that in part, decision-making 
in the IGT was moderated by intelligence level, medication and general symptom scores. 
Conclusion: Our results indicate robust impairments in reward-based decision-making in SZP 
and suggest that decreased cognitive resources, such as working memory, may contribute to 
these alterations. 
Keywords: schizophrenia, decision-making, reward, Iowa Gambling Task, meta-
analysis, linear modeling 
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1. Introduction 
Patients with schizophrenia (SZP) exhibit deficits across a wide range of measures of 
executive control/working memory (WM; Collins et al., 2014) and reward-
processing/reinforcement learning (RL; Gold et al., 2008; Juckel et al., 2006; Strauss et al., 
2012; Waltz et al., 2007). A particularly debilitating aspect of the illness potentially 
associated with these impairments is maladaptive decision-making, contributing significantly 
to several functional deficits, such as poor treatment adherence, financial difficulties and 
interpersonal conflicts (Fond et al., 2013).  
One popular experimental paradigm to examine decision-making making under 
ambiguity in SZP is the Iowa Gambling Task (IGT; Bechara et al., 1994). On each trial, 
participants choose a card from one of four decks and receive a monetary gain or loss. The 
decks differ in three properties: the amount of immediate gain, the relative frequency of gains 
vs. losses (gain frequency) and the relative number of net losses, i.e., the number of instances 
when the sum of gains and losses on a card is below zero (net losses). The combination of 
these features is unique for each deck and unknown to the participants (supplementary tables 
1-2). The goal is to maximize monetary outcome through adaptive decision-making in 100 
trials: two decks (A, B) are disadvantageous; two decks (C, D) are advantageous. 
To disentangle the factors underlying IGT performance, computational cognitive 
models such as the Expectancy Valence Learning (EVL) model have been employed 
(Busemeyer and Stout, 2002) to quantify latent cognitive components (attention to gains, 
learning rate, recency, response consistency) and a least-squares model has been used to 
identify the relative importance of the deck features (supplementary tables 1-2) in decision-
making (Horstmann et al., 2012). 
Previous research has evidenced the important role of high-level cognitive functions, 
especially memory (WM), for successful performance in the IGT (Bagneux et al., 2013; 
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Demaree et al., 2010; Hawthorne and Pierce, 2015; Maia and McClelland, 2004; Stocco et 
al., 2009). In SZP, impaired WM is arguably a core symptom related to prefrontal 
abnormalities, as supported by behavioral observations (Anticevic et al., 2011; Collins et al., 
2014; Park et al., 1999; Strauss et al., 2012), consistent hypofrontality during WM tasks 
(Glahn et al., 2005) and alterations of prefrontal D1 receptor transmission involved in WM 
deficits (Abi-Dargham et al., 2002).  
 Importantly, WM interacts with basic processes of reinforcement learning (RL) in 
learning paradigms (Collins et al., 2017), making the dopaminergic system – implicated in 
reward processing (Pizzagalli et al., 2008; Schultz et al., 1997; St Onge and Floresco, 2009) – 
another factor in IGT performance. Deficient task performance may therefore also be linked 
to well-documented alterations in the dopaminergic system of SZP (Carlsson, 1988), 
specifically increased striatal dopamine synthesis capacity (Howes et al., 2012) interfering 
with reward prediction errors (Juckel et al., 2006). 
A previous meta-analysis of eight studies revealed that SZP showed poor performance 
compared to HC in the IGT, potentially stemming from a RL deficit (Brown et al., 2015). 
However, only deck choices were meta-analyzed and moderator variables were not accounted 
for. Lastly, the specific pattern of suboptimal deck choices in schizophrenia was not 
examined formally, e.g. with a model. Therefore, we employed a meta-analytic approach to 
integrate a larger body of available evidence to evaluate the differences in decision-making 
between SZP and HC in several outcome measures of the IGT: block net scores, deck 
choices, and EVL model parameters. Our secondary goal was to investigate the moderating 
effects of demographical and clinical variables on the difference in IGT performance between 
HC and SZP. Third, to validate the results from the meta-analysis, we used original, subject-
level data for modeling decision-making behavior of SZP and HC in the IGT. Lastly, we 
modeled the influence of the statistical properties of the decks (frequency and magnitude of 
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gains/losses; net losses) on decision-making in SZP relative to HC to gain insight into the 
nature of their deficits on the IGT (Horstmann et al., 2012).   
2. Methods 
2.1 Literature Search and Data Extraction 
 Following recommended guidelines as defined in the PRISMA statement (Moher et al., 
2009), we conducted a systematic literature search in the databases PubMed, PsycINFO, and 
Web of Science in November 2017 using the search term (“psychosis” OR “psychotic” OR 
“schizophrenia” OR “schizophrenic”) AND (“Iowa Gambling task” OR “Gambling task” OR 
“Bechara Gambling task”), searching for studies published between 1990/01/01 and 
2017/11/15. Reference lists of published reviews and studies were used to identify additional 
publications. To be included, a study had to (1) include a sample of SZP or schizoaffective 
disorder as defined by the DSM IV, (2) include a sample of healthy control participants 
matched for age (case-matched or no significant differences in mean age between the 
groups), (3) report results from the IGT in a way that sufficient information could be 
extracted to calculate at least one of the effect sizes of interest (net score in each of the five 
blocks, total number of cards selected from each of the individual decks, parameters from 
computational modeling). From all included studies, we extracted means, standard deviations 
and group sizes to calculate the standardized mean difference (SMD, expressed as d; Hedges, 
1981) between SZP and HC for block net scores, deck choices and/or model parameters, as 
well as moderator variables (year of publication, continent where the study was conducted, 
quality of the study (derived from an adapted version of the Newcastle-Ottawa Scale, Wells 
et al., 2000, supplementary table 3), demographic information of the control and patient 
sample (age, gender, years of education, intelligence quotient (IQ) levels), and clinical 
characteristics of the patient sample (illness duration, age of onset, symptom ratings [Positive 
and Negative Symptom Scale (PANSS); Kay et al., 1987], amount of current neuroleptic 
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medication [chlorpromazine equivalents (CPZE)], percent of SZP medicated with 
antipsychotics, percent of SZP medicated with first-generation antipsychotics) 
(supplementary methods for details on data extraction). 
2.3 Statistical Analysis 
2.3.1 Meta-analysis. Psychiatric populations are typically heterogeneous due to 
differences in illness duration, previous medication and symptoms. To account for this 
heterogeneity, we employed random-effects meta-analysis models. We inspected funnel plots 
and tested for funnel plot asymmetry using Egger’s test (Egger et al., 1997). If Egger’s test 
was significant, we used the trim-and-fill method to estimate the number of missing studies 
and correct the estimated effect size (Duval and Tweedie, 2000a, 2000b). When important 
heterogeneity was identified, we used random effects univariate meta-regression models to 
examine whether any of the extracted variables described above were associated with 
performance differences between SZP and HC. 
2.3.2 Behavioral modeling. To increase statistical power compared to the meta-
analysis based on summary data, we fitted linear mixed-effects models to a subset of original, 
patient-level data to investigate differences in decision-making between HC and SZP for each 
of the IGT-outcomes of interest (block net scores, deck choices), pooling available data and 
including study as a random effect. We also investigated moderating effects of the 
demographic and clinical variables detailed above (supplementary methods 1). 
2.3.3 Least-Squares modeling. We modeled decision-making on the IGT with a system 
of linear equations, as Xb = y (Horstmann et al., 2012). Least-squares provides a solution b 
for the system, describing a linear relationship between the statistical properties of the decks 
(supplementary tables 1-2) included in X and the deck choices in y (supplementary methods 
2). We applied this model to aggregated and subject-level deck choices. To explore 
moderation effects on the model parameters, we used linear mixed-effects models.  
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We conducted all analyses in the R statistical language for computing, version 3.4.2 (R 
Core Team, 2017) using the packages ‘metafor’ (Viechtbauer, 2010), ‘lme4’ (Bates et al., 
2015) and ‘lmerTest’ (Kuznetsova et al., 2015). We obtained p-values for the coefficients in 
the linear mixed-effects models based on the Satterthwaite approximation for denominator 
degrees of freedom implemented in lmerTest. A significance level of p = .05 was considered 
throughout. 
2. Results 
Twenty-nine samples described in 27 publications [two articles (Raffard et al., 2011; 
Sevy et al., 2007) reported data from two samples each] met our inclusion criteria and were 
included in the analyses (figure 1; included studies in supplementary table 4; study/sample 
characteristics and moderator variables in supplementary table 5). In total, this comprised n = 
1127 SZP and n = 1149 HC.  
3.1 Meta-analyses and meta-regression 
Table 1 provides a summary of the meta-analysis results for all IGT indices. 
3.1.1 Block net scores. Twenty-five samples from 23 publications (two studies 
(Raffard et al., 2011; Sevy et al., 2007) described data from two samples each) with a total of 
n=965 SZP and n=921 HC reported block net scores. Meta-analyses indicated significant 
reductions of net scores in SZP in block 2 (d=-0.34, 95%-CI: -0.51 to -0.18, p < .001, I² = 
66.2%), block 3 (d=-0.70, -0.96 to -0.44, p < .001, I²=85.1%), block 4 (d=-0.94, -1.25 to -
0.63, p < .001, I²=89.5%) and block 5 (d=-1.06, -1.50 to -0.63, p < .001, I²=94.5%; figure 3) 
as compared to HC, but not in block 1 (d=0.09, -0.04 to 0.23, p=.154, I²=44.7%) (figure 2A 
and supplementary figures 1A-5). Egger’s test was significant for block 5 (z=-2.81, p=.005) 
and trim-and-fill analysis suggested that six studies were potentially ‘missing’ on the right-
hand side of the funnel plot (p=.008, supplementary figure 6). After imputing these putatively 
missing studies, the mean effect size was -0.58 (-1.13 to -0.04, p=.035, I²=97.0%). Meta-
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regression indicated that later mean age of illness onset was associated with a smaller 
difference between SZP and HC in block 5 net scores (number of studies that reported the 
moderator variable k=10, β=0.15, Standard Error (SE)=0.06, p=.016). This finding was 
mainly driven by the early-onset schizophrenia sample of Kester et al. (2006). When 
excluded, the moderator effect was no longer significant (supplementary results). 
3.1.2 Deck choices. Seventeen studies from 16 publications (one study (Sevy et al., 
2007) described data from two samples) comprising n=648 SZP and n=566 HC reported deck 
choices. Meta-analyses indicated significant increases in the number of cards chosen from 
deck A (d=0.35, 0.21 to 0.49, p < .001, I²=25.54%) and deck B (d=0.51, 0.29 to 0.71, p < 
.001, I²=68.19%, figure 4) in SZP compared to HC. Conversely, SZP drew significantly less 
cards from deck D (d=-0.62, -0.84 to -0.41, p < .001, I²=66.13%) than HC. Choices from 
deck C were not significantly different between the groups (d=-0.13, -0.37 to 0.11, p=.278, 
I²=73.92%) (figure 2B and supplementary figures 7-9).  
Meta-regression indicated that higher level of education in the control sample was 
associated with increased choices from deck A in SZP compared to HC (k=16, 
β=0.08, SE=0.04, p=.029). Additionally, there was evidence for a relative decrease in choices 
from deck A in SZP compared to HC with increasing IQ (k=11, β=-0.04, SE=0.02, p=.009), 
higher positive (k=9, β=-0.05, SE=0.02, p=.04), higher general psychopathology (k=7, β=-
0.02, SE=0.01, p=.04) and higher total PANSS scores in the patient sample (k=11, β=-
0.009, SE=0.004, p=.024). Similarly, lower rates of antipsychotic-medicated patients in the 
sample were associated with a decrease in choices from deck A (k=5, 
β=0.58, SE=0.20, p=.004) and an increase in cards chosen from deck B (k=5, β=-
0.92, SE=0.37, p=.012). These effects were driven by the Zhang et al. (2015) study. When 
excluded, the moderator effects were no longer significant (supplementary results).  
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3.1.3 EVL model parameters. Five samples from four publications (one study (Sevy et 
al., 2007) included two samples) reported EVL model parameters (n=187 SZP and n=230 
HC). Meta-analyses indicated no significant differences between SZP and HC in any of the 
model parameters (attention to gains/losses (d=0.06, -0.15 to 0.26, p=.597, I²=0.0%), 
response consistency (d=-0.01, -0.47 to 0.44, p=.958, I²=73.75%), learning rate (d=0.15, -
0.32 to 0.62, p=.524, I²=75.13%) (figure 2C and supplementary figures 10-12). Egger’s test 
was significant for response consistency (z=4.05, p < .001) and learning rate (z=-3.97, p < 
.001). Trim-and-fill analyses detected no ‘missing’ studies in both cases (p=.50; 
supplementary figures 13-14). Due to the small number of studies, we do not report 
moderator analyses in this section.  
3.2 Modeling based on individual subject data 
Original individual subject data comprised n = 491 subjects (303 SZP and 188 HC) 
provided by authors of five studies included in the meta-analysis (Hori et al., 2014; Kim et 
al., 2009; Kim and Kang, 2016; Premkumar et al., 2008; Raffard et al., 2011).  
3.2.1 Behavioral modeling of block net scores. Block net scores were available for all 
n=491 subjects. In line with our meta-analysis, linear mixed-effect models indicated that 
diagnosis was associated with lower block net scores in SZP compared to HC during block 2 
(β =-1.90, SE=0.75, p=.026), block 3 (β=-4.36, SE=0.82, p < .001), block 4 (β=-6.00, 
SE=0.96, p < .001), and block 5 (β=-7.00, SE=1.13, p < .001), but not during block 1 (p 
=.722) (supplementary figure 15A). In n=391 subjects (228 SZP, 163 HC), we examined the 
role of moderator effects (gender, age, IQ) on block net scores. Analogously, we examined 
these moderator effects in n=207 subjects (125 SZP, 82 HC) for whom deck choices were 
available. Results indicated an interaction effect of diagnosis and IQ scores on block 2 net 
scores in patients and controls: IQ scores were positively correlated with block net scores in 
HC, while this relationship was attenuated in patients (β=-0.14, SE=0.07, p=.038). Higher net 
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scores in block 3 were associated with higher IQ scores in both groups (β=0.11, SE=0.06, 
p=.049). In data from n=228 SZP, higher doses of medication were associated with 
significantly decreased net scores during block 1 (β=-0.76, SE 0.37, p = .042), block 2 (β=-
0.90, SE=0.43, p=.041) and at non-significant trend-level during block 3 (β=-0.78, SE=0.45, 
p=.085). Additionally, there was a trend suggesting that higher PANSS general symptom 
scores were associated lower net scores in block 4 (β=-0.15, SE=0.08, p=.073).  
3.2.2 Behavioral modeling of deck choices. Deck choices were available for n=207 
subjects (125 SZP, 82 HC). In accordance with the meta-analyses, linear mixed-effect models 
indicated that SZP selected significantly more cards from deck A (β=-2.22, SE=1.00, p 
=.027) and B (β=5.93, SE=1.49, p < .001) than HC, but less cards from deck C (β=-5.95, 
SE=1.24, p < .001). Results for deck D were not significant (p=.126). (supplementary figure 
15B). Moderator analyses showed that IQ scores differentially affected choices from deck B: 
higher IQ scores resulted in decreased choices from deck B in HC, but this effect was 
attenuated in SZP (β=0.39, SE=0.14, p=.009). A linear mixed-effect model based on data 
from n=125 SZP identified a non-significant trend indicating that higher PANSS general 
symptom scores were linked to fewer cards selected from deck C (β=-0.16, SE = 0.09, 
p=.069). 
3.3 Least-Squares modeling 
Linear mixed-effects models based on aggregated data indicated an increase in 
immediate gain in patients relative to controls (β=5.87, SE=0.81, p < .001). Patients gave less 
weight to gain frequency (β=-1.93, SE=0.83, p=.033), and net loss (β=-2.79, SE=0.67, p < 
.001). Results from subject-level data were similar for immediate gains (β=-4.48, SE=1.36, 
p=.001), but different for gain frequency (β=2.34, SE=0.90, p=.010) and net loss (β=0.13, 
SE=1.15, p =.907) (figure 5). 
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The moderator analyses conducted on subject-level data revealed a significant 
interaction of IQ scores and diagnosis that moderated immediate gain (β=0.49, SE=0.14, p < 
.001), gain frequency (β=-0.24, SE=0.09, p=.011), indicating that in HC, higher IQ scores 
resulted in less weighting of immediate gain and increased weighting of gain frequency, 
while these relationships were attenuated or reversed in patients. Additionally, we observed 
non-significant trends indicating that the weighting of gain frequency decreased with higher 
negative symptoms (β=-0.17, SE=0.10, p=.093) and that the weighting of immediate gains 
was increased with higher general symptom scores (β=0.22, SE=0.13, p=.096) in SZP. 
3. Discussion 
We present a meta-analysis of k = 29 samples from 27 publications (n=1127 SZP, 
n=1149 HC) as well as a comprehensive analysis of subject-level data (n=303 SZP and 
n=188 HC). Our results demonstrate impaired decision-making in SZP compared to HC in 
the IGT with small to large effect sizes, depending on the IGT index. HC maximized net 
scores, displaying a steep learning curve, while SZP did not improve during the task. Across 
studies, patients chose significantly more cards from the momentary profitable, but overall 
disadvantageous decks, whereas HC selected significantly more cards from the advantageous 
deck D. Importantly, these results were robust with respect to potential publication biases and 
the inclusion of confounding factors (including year of publication, study quality, continent 
where the study was conducted) and the results could be confirmed with subject-level data.  
Findings from the meta-analysis revealed a pattern of deck selections that is specific to 
schizophrenia: while SZP and controls selected deck C with similar frequency, SZP selected 
decks A and B more frequently and deck D less frequently than HC. Deck B is associated 
with frequent high gains and rare, but very large losses, resulting in an overall 
disadvantageous outcome. Despite this negative long-term balance, HC also frequently pick 
deck B (Dunn et al., 2006; Lin et al., 2007). In line with previous literature (Horstmann et al., 
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2012), the least-squares model showed that decision-making in HC is primarily driven by 
gain frequency as indicated by a relative preference for decks with high-frequency gains (B 
and D). Additionally, HC distinguish between the decks with low-frequency gains by 
weighting net losses negatively: they choose deck C (which never yields a net loss) over deck 
A (which yields frequent net losses). In contrast, SZP decision-making was mainly driven by 
net losses and immediate gains. Most interestingly, patients seem to prefer deck B by a large 
margin over all other decks for other reasons than controls: while controls are attracted by the 
high gain frequency associated with this deck, patients are drawn to deck B due to a 
combined influence of low net losses and high immediate gains. These findings might 
illustrate how patients disregard long-term outcome in their decision-making and focus on 
high immediate gains. This pattern of decision-making is in keeping with reported intact 
sensitivity to immediate and reliable rewards in schizophrenia, as opposed to more complex 
or temporally remote rewards (Heerey et al., 2008; Juckel et al., 2006; Waltz et al., 2007).  
Past research has indicated that the IGT is a cognitively demanding task requiring high-
level cognitive functions such as holding the experimental contingencies in WM (Bagneux et 
al., 2013; Demaree et al., 2010; Hawthorne and Pierce, 2015; Maia and McClelland, 2004; 
Stocco et al., 2009). Integration of information across decks and trials is particularly 
important to capture gain frequency since this parameter differs between decks A/C and 
decks B/D. Net losses, by contrast, can be incorporated into decision-making relatively easily 
since deck A is the only deck with markedly high net losses, obviously differing from all 
other decks. Similarly, capturing high immediate gains does not require active maintenance 
of information. Thus, the pattern of decision-making found in SZP may suggest that they rely 
more on deck features that pose less load on their WM system. These parameters may be 
captured by integrating outcome magnitudes using trial-by-trial RL processes, which seem to 
be relatively spared in schizophrenia (Collins et al., 2017; Heerey et al., 2008). Importantly, 
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even patients with comparatively intact cognitive resources do not show altered decision-
making strategies: contrary to HC, patients with higher IQ scores do not change their 
weighing in favor of gain frequency and against immediate gains. It has been speculated that 
such a pattern of behavior mirrors patients’ reduced confidence in their WM capacities 
(Collins et al., 2014). Alternatively, PFC-dependent motivational factors, such as willingness 
to expend effort, may influence patients’ decision-making (Barch et al., 2014). Given that no 
direct measure of WM nor motivation was assessed in this meta-analysis, the determinants of 
the specific pattern of IGT-performance warrant further investigation. 
Our data suggest that decision-making in the IGT is negatively influenced by high doses 
of neuroleptic medication, especially during the initial blocks when intact WM functioning 
seems to be critically involved in learning the deck contingencies (Hawthorne and Pierce, 
2015; Horstmann et al., 2012; Stocco et al., 2009). Chronic dopamine blockage may 
exacerbate WM dysfunction in schizophrenia as proposed by the inverted U-shaped 
relationship between dopamine levels and WM function (Cools and D'Esposito, 2011). The 
use of the deck feature gain frequency, which is strongly dependent on WM and central to 
successful task performance in controls, may be particularly affected by antipsychotics. 
Conversely, trial-by-trial aspects of RL associated with striatal-dopaminergic signaling that 
seem to be normalized by antipsychotic medication (Insel et al., 2014) may only be 
secondary to succeeding in the IGT. Such effects, however, are difficult to distinguish from 
general effects of illness severity on task performance also suggested by the data.  
4. Limitations 
The limited range of some of the moderator variables may have contributed to their 
relative nonsignificance in the present analyses. The patient samples analyzed were relatively 
homogeneous in terms of stability and chronicity of the illness, age of onset and type and 
amount of antipsychotic medication, and data on treatment duration was largely unavailable 
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across studies. This makes it difficult to assess in more detail the effects of disease 
progression or duration and type of antipsychotic medication known to influence the 
performance on neuropsychological tests associated with IGT performance (Premkumar et 
al., 2008; Yip et al., 2009).  
Additionally, some of the observed moderator effects were driven by single outlier 
studies. The early-onset schizophrenia sample (Kester et al., 2006) showed particularly poor 
task performance, potentially driven by more pronounced WM dysfunction in this population 
compared to adult-onset schizophrenia (Frangou, 2009). Similarly, the only available sample 
of drug-naïve patients (Zhang et al., 2015) showed altered decision-making by means of a 
strong focus on decks with high immediate gains. However, drug-naïvety co-occurred with 
high symptomatology and intelligence in this sample, complicating the evaluation of the role 
of medication. Thus, conclusions on these moderator effects should be tentative and 
substantiated by further research. 
The aggregation of data inherent to the process of meta-analysis leads to a loss of 
information and potentially imprecise results. We tried to reduce this risk by validating our 
results with the help of original data. Results could be confirmed overall, but discrepancies in 
deck choices and least-squares parameters emerged. Subject-level analyses of these outcomes 
were based on data from two studies only, compromising the generalizability of these results. 
Especially, behavior of HC reported in these studies differed from the aggregated findings in 
the meta-analysis. Varying eligibility criteria for HC across studies may account for some of 
the heterogeneity in IGT performance observed in our and previous analyses (Steingroever et 
al., 2013). 
Moreover, even in the analyses at subject-level, data was aggregated per block and 
deck. This may have led to an underestimation of the importance of aspects of RL that are 
primarily reflected in changes in deck choices from trial to trial of participants, e.g. prolonged 
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sampling across or adaptive switching between decks. Using trial-by-trial data, more detailed 
cognitive modeling is possible: Recent computational cognitive models like the Prospect 
Valence Learning (PVL) model have revised details for utility, learning and choice 
probability functions and can model complex decision-making more accurately than the EVL 
model (Ahn et al., 2008; Fridberg et al., 2010). Similarly, modeling of changes of weighting 
of deck features across blocks may provide valuable insights into the adaptation of decision-
making of SZP (Horstmann et al., 2012). 
5. Conclusion and clinical implications 
The deficits of SZP in the IGT were demonstrated in meta-analyses across 29 samples 
from 27 publications and overall confirmed by comprehensive modeling of individual subject 
data. A least-squares model illustrated that these deficits are primarily driven by an impaired 
integration of information about the relative frequency of gains vs. losses and an over-
weighting of immediate gains suggesting that a WM deficit may contribute to suboptimal 
task performance in schizophrenia. This pattern of decision-making may relate to several 
behavioral patterns that pose problems in the treatment of SZP, such as poor medication 
adherence or substance abuse (Pristach and Smith, 1990). Therapeutic interventions should 
account for this decision-making behavior neglecting long-term outcome, e.g. by imparting 
strategies to increase the awareness of long-term consequences of actions (Evans et al., 
2005). Additionally, assuring medication delivery using long-acting injectable medication 
can help to optimize treatment success in SZP (Barnes and Cursori, 1994). 
 
Figure Legends: 
Figure 1. Overview of the different stages of the systematic literature search according to the 
PRISMA guidelines (Moher et al., 2009).  
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Figure 2. Results from the meta-analysis. Weighted averages (by sample size) for patients 
with schizophrenia (SZP) and healthy controls (HC). (A) Net scores during the five blocks of 
the Iowa Gambling Task. (B) Mean number of cards chosen from each deck. (C) Parameters 
from the Expectancy-Valence (EVL) model. Atten = Attention to Gains versus Losses, Cons 
= Response Consistency, Learn = Learning Rate/Recency Parameter. Error bars represent the 
95% confidence interval. ***p < .001. 
 
Figure 3. Forest plot of the standardized mean difference between schizophrenic patients 
(SZP) and healthy controls (HC) in block 5 net score of the Iowa Gambling Task. 
Annotation: Raffard et al., 2011a: high insight SZP, Raffard et al., 2011b: low insight SZP; 
Sevy et al., 2007a: SZP without cannabis use disorder, Sevy et al., 2007b: SZP with cannabis 
use disorder. 
 
Figure 4. Forest plot of the standardized mean difference between patients with 
schizophrenia (SZP) and healthy controls (HC) in the number of cards chosen from deck B in 
the Iowa Gambling Task. Annotation: Sevy et al., 2007a: SZP without cannabis use disorder, 
Sevy et al., 2007b: SZP with cannabis use disorder. 
 
Figure 5. Results from least-squares modeling for patients with schizophrenia (SZP) and 
healthy controls (HC). (A) Weighted mean (by sample size) of the weights of least-squares 
modeling parameters. The model was applied to the aggregated deck choices reported in the 
studies included in the meta-analysis. (B) Mean weight of the parameters derived from 
applying the least-squares model to subject-level data. Error bars represent the 95% 
confidence interval. *p < .05, **p < .01 
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Table: 
Table 1. Summary table for meta-analysis results for all IGT indices. 
IGT index 
k 
Effect 
Sizes 
k 
Studies 
n 
(SZP) 
n (HC) SMD 95%-CI z p 
I² (in 
%) 
Egger’s test 
z                  p 
Net Score 
 Block 1 25 23 965 921 0.09 [-0.04, 0.23] 1.43 .15 44.7 0.05 .957 
 Block 2 25 23 965 921 -0.34 [-0.51, -0.18] -4.01 <.001 66.2 -0.60 .550 
 Block 3 25 23 965 921 -0.70 [-0.96, -0.44] -5.30 <.001 85.1 -0.30 .764 
 Block 4 25 23 965 921 -0.94 [-1.25, -0.63] -5.89 <.001 89.5 -1.03 .305 
 Block 5 25 23 965 921 -1.06 [-1.50, -0.63] -4.77 <.001 94.5 -2.81 .005 
Deck Choice 
 Deck A 17 16 648 566 0.35 [0.21, 0.49] 4.91 <.001 25.5 1.92 .054 
 Deck B 17 16 648 566 0.51 [0.29, 0.71] 4.53 <.001 68.2 0.43 .667 
 Deck C 17 16 648 566 -0.13 [0.37, 0.11] -1.08 .278 73.9 -0.15 .879 
 Deck D 17 16 648 566 -0.62 [-0.84, -0.41] -5.69 <.001 66.1 -0.96 .337 
EVL-Model  
Parameters 
 attention to   
gains/losses 
5 4 187 230 0.06 [-0.15, 0.26] 0.53 .597 0.0 0.53 .599 
 response 
consistency 
5 4 187 230 -0.01 [-0.47, 0.44] -0.05 .958 73.8 4.05 <.001 
learning rate 5 4 187 230 0.15 [-0.32, 0.62] 0.64 0.525 75.1 -3.97 <.001 
Abbreviations: IGT = Iowa Gambling Task, N = Number, SZP = Patient with schizophrenia, HC = 
Healthy control, SMD = Standardized Mean Difference, CI = Confidence Interval, z = z-value, p = p-
value, EVL = Expectancy-Valence Learning.  
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